Litcius/Paper detail

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis

Eileen O’Meara, Michael McDonald, Michael Chan, Anique Ducharme, Justin A. Ezekowitz, Nadia Giannetti, Adam Grzeslo, George Heckman, Jonathan G. Howlett, Sheri L. Koshman, Serge Lepage, Lisa Mielniczuk, Gordon W. Moe, Elizabeth Swiggum, Mustafa Toma, Sean Virani, Shelley Zieroth, Sabe De, Sylvain Matteau, Marie-Claude Parent, Anita Asgar, Gideon Cohen, Nowell M. Fine, Margot K. Davis, Subodh Verma, David Z.I. Cherney, Howard Abrams, Abdul Al‐Hesayen, Alain Cohen‐Solal, Michel D’Astous, Diego Delgado, Olivier Desplantie, E. Estrella-Holder, Lee A. Green, Haissam Haddad, Karen Harkness, Adrian F. Hernandez, Simon Kouz, Marie-Hélène Leblanc, Douglas S. Lee, Frederick A. Masoudi, Robert S. McKelvie, Miroslaw Rajda, Heather J. Ross, Bruce Sussex

2020Canadian Journal of Cardiology121 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHeart failure with preserved ejection fractionCardiac amyloidosisEjection fractionHeart failureInternal medicineCardiologyMitral regurgitationAtrial fibrillationClinical trialIntensive care medicineSacubitrilDiabetes mellitusEndocrinologyAmyloidosis: Diagnosis, Treatment, OutcomesDiabetes Treatment and ManagementPeptidase Inhibition and Analysis